New Guidelines from the ACR For Lupus Care During COVID-19 Pandemic
June 9, 2020
The American College of Rheumatology enlisted 14 experts on infectious diseases and immune system illnesses to develop...
News
A Message From LRA President & Ceo on COVID-19 and Lupus
These are challenging times for everyone-and each of us must stay focused. For the Lupus Research Alliance (LRA) this...
Watch Video of Webcast: Lupus and Cognitive Health
Watch a videotape of our recent webcast: Lupus and Cognitive Health
Presented by LRA’s Young Leaders Board
People with lupus know...
Promising News from Major Medical Meeting, EULAR
Updated June 5, 2020
One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...
Lupus Research Alliance Issues Statement June 4, 2020
June 4, 2020
Racism, bigotry, intolerance and violence are hateful and have no place in American society.
The Lupus Research Alliance...
Positive Data from Trial of Investigational Treatment KZR-616 for Lupus and Lupus Nephritis
June 3, 2020
Kezar Life Sciences, Inc. today announced updated results from the Phase 1b (Ph1b) portion of MISSION, a...
LRA Congratulates AstraZeneca on Positive Data on Anifrolumab Presented at Major Medical Meeting
June 3, 2020
The Lupus Research Alliance (LRA) is encouraged by positive data from two studies presented at the European...
Aurinia Completes NDA and Requests Priority Review of Voclosoporin by FDA for Lupus Nephritis
May 28, 2020
The Lupus Research Alliance is pleased to share that Aurinia Pharmaceuticals Inc submitted a New Drug Application...
COVID-19 Caused Hydroxychloroquine Issues for Third of Lupus Patients, New LRA Survey Finds
NEW YORK, NY, May 28, 2020. More than one third of people with lupus experienced significant issues filling their...
Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET
Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine...
Remembering Betty Wold Johnson, A Major LRA Friend and Benefactor
May 2020
The entire Board of Trustees and staff of the Lupus Research Alliance (LRA) and Lupus Therapeutics (LT) mourn...
Lupus Research Alliance Thanks FDA for Responsiveness Re Letter Citing Plaquenil Shortages
May 7, 2020
The Lupus Research Alliance held an informative call with the Food and Drug Administration (FDA) in response...